Author

Yu‐Yun Du

Observed name: Yu-Yun Du

Institution: Sun Yat-sen University Cancer Center

Observed institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China

OpenAlex ID: A5113880241

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response

2019 · Sai-Lan Liu, Xue-Song Sun, et al. · Radiotherapy and Oncology · 68

Combining pretreatment plasma Epstein‐Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study

2019 · Yu‐Yun Du, Dong‐Hua Luo, et al. · Cancer Medicine · 30

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level

2020 · Sai-Lan Liu, Xue-Song Sun, et al. · BMC Cancer · 26

The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era

2018 · Ya-Nan Jin, Wang-Jian Zhang, et al. · Cancer Research and Treatment · 25

Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score–matched analysis

2018 · Yu-Jing Liang, Lin-Quan Tang, et al. · BMC Cancer · 14

Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma

2021 · Wan-Ru Zhang, Yu-Yun Du, et al. · Cancer Research and Treatment · 5

Works count: 6

Citation count: 168

H-index: 5

I10-index: 5